跳轉至內容
Merck
全部照片(1)

文件

639869

Sigma-Aldrich

4-苯基哌啶

97%

登入查看組織和合約定價
全部照片(1)

About This Item

經驗公式（希爾表示法）:
C11H15N
CAS號碼:
771-99-3
分子量：:
161.24
Beilstein:
124508
EC號碼:
212-243-1
MDL號碼:
MFCD00006002
分類程式碼代碼:
12352100
PubChem物質ID:
24883062
NACRES:
NA.22

化驗

97%

mp

61-65 °C (lit.)

SMILES 字串

C1CC(CCN1)c2ccccc2

InChI

1S/C11H15N/c1-2-4-10(5-3-1)11-6-8-12-9-7-11/h1-5,11-12H,6-9H2

InChI 密鑰

UTBULQCHEUWJNV-UHFFFAOYSA-N

尋找類似的產品？ 前往 產品比較指南

相關類別

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H315,H319,H335

危險分類

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。

已經擁有該產品？

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Clandestine drug synthesis.
W H Soine
Medicinal research reviews, 6(1), 41-74 (1986-01-01)
Diane K Luci et al.
Bioorganic & medicinal chemistry letters, 17(23), 6489-6492 (2007-10-16)
Various 4-phenylpiperidine-benzoxazin-3-ones were synthesized and biologically evaluated as urotensin-II (U-II) receptor antagonists. Compound 12i was identified from in vitro evaluation as a low nanomolar antagonist against both rat and human U-II receptors. This compound showed in vivo efficacy in reversing
A G Ishkov et al.
Voprosy meditsinskoi khimii, 38(2), 25-28 (1992-03-01)
A rate of utilization of 4-phenyl piperidine and its 12 derivatives by brain monoamine oxidase (MAO) was studied as compared with typical neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The enzyme was isolated from P2 synaptosomal fraction of brain corpus striatum of Sprague-Dawley rats.
Barbara Wenzel et al.
Bioorganic & medicinal chemistry letters, 22(6), 2163-2166 (2012-03-01)
This Letter describes the synthesis of two regioisomers of a new class of vesamicol analogs as possible ligands for imaging the vesicular acetylcholine transporter in future PET studies. The two pyrrolovesamicols (±)-6a and (±)-6b were synthesized by nucleophilic ring opening
R A Glennon et al.
Journal of medicinal chemistry, 34(12), 3360-3365 (1991-12-01)
sigma receptors may represent an exciting new approach for the development of novel psychotherapeutic agents. Unfortunately, many of the commonly used sigma ligands lack selectivity (e.g., many bind at phencyclidine or dopamine receptors) or suffer from other serious drawbacks. Recently
查看所有相關論文

我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務